SCHEMBL7324311

SCHEMBL7324311

Clc1cc(CCc2ccccn2)c2oc(-c3cnc4ccccc4n3)nc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
ALDH1A1 P00352 4/20 0.40
HSD17B10 Q99714 4/20 0.40
HPGD P15428 3/20 0.40
TP53 P04637 2/20 0.40
PDE10A Q9Y233 2/20 0.36
ADORA3 P0DMS8 3/20 0.35
ADORA1 P30542 2/20 0.35
CYP1A2 P05177 3/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
MKNK1 Q9BUB5 1/20 0.35
MKNK2 Q9HBH9 1/20 0.35
HSP90AA1 P07900 1/20 0.33
CYP2D6 P10635 2/20 0.33
CYP3A4 P08684 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7315751 0.85 RAB9A (0.43) KDM4ESMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL7317091 0.85 PDGFRB (0.38) KDM4ESMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL7322971 0.81 NPC1 (0.41) KDM4ESMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL7315804 0.80 ALDH1A1 (0.36) KDM4ESMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL7321855 0.79 KDM4E (0.36) KDM4ESMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL7314123 0.79 KDM4E (0.37) KDM4ESMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL7318937 0.78 CHRNA7 (0.38) KDM4ESMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL7317490 0.78 KDM4E (0.40) KDM4ESMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL7324755 0.78 ALDH1A1 (0.37) KDM4ESMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL7324750 0.77 STAT6 (0.38) KDM4ESMN1; SMN2NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6166041-A 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma EURO-CELTIQUE, S.A. (LU) 2000-12-26 US claimed
US-6166041-A 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma EURO-CELTIQUE, S.A. (LU) 2000-12-26 US disclosed